January 16, 21 - 5:49 pm - LABS

Brazil’s União Química asks emergency use approval for Russian vaccine

Brazilian pharmaceutical firm União Química said on Friday that, together with the Russian Direct Investment Fund (RDIF), it has requested regulatory approval for emergency use of COVID-19 vaccine Sputnik V, reported Reuters.

Filed with Brazilian health regulator Anvisa, the request attempts approval for the use of 10 million doses of Sputnik V in Brazil in the first quarter of 2021, the company said in a statement issued in Moscow. Anvisa said the Russian vaccine would have to be submitted to Phase III clinical trials in Brazil before being authorized for use.